Home » Topics » BioWorld Science

BioWorld Science
RSS

ADC Therapeutics terminates its ADCT-502 program in HER2-expressing solid tumors

April 26, 2018

Ono applies for manufacturing and marketing approval of encorafenib and binimetinib in Japan

April 26, 2018

Mirati Therapeutics updates progress of key programs

April 26, 2018

FDA grants orphan drug designation to Lin's LBS-007

April 26, 2018

Orexigen announces asset purchase agreement for sale of company

April 25, 2018

Alkahest initiates phase II study of GRF-6019 in Alzheimer's disease

April 25, 2018

FDA approves expanded indication for Trelegy Ellipta in COPD

April 25, 2018

Novel CDK4/6 inhibitor TQB-3616 presented for cancer therapy

April 25, 2018

FDA grants fast track designation to EC-18 for chemoradiation-induced oral mucositis

April 25, 2018

Synthetic Biologics withdraws breakthrough therapy designation for ribaxamase

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...